Premium Lendomy 5mg UAE | Leading Pharmaceutical Exporter from India

Lendomy 5mg Capsule: Premier Immunomodulatory Therapy for Targeted Oncology

Are you searching for a reliable Lendomy 5 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of advanced oncology medications. We cater to high-demand international markets, including the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, providing high-quality pharmaceutical solutions with professional B2B support.

Detailed Product Overview: What is Lendomy 5mg?

Lendomy 5 mg is an oral medication containing the active ingredient Lenalidomide. It is classified as an Immunomodulatory Agent (IMiD) and is a cornerstone in the management of several types of hematological malignancies (blood cancers).

By modulating the body's immune system and directly attacking malignant cells, Lendomy 5 mg offers a targeted approach to cancer therapy, often providing a vital alternative or supplement to traditional chemotherapy.

Primary Therapeutic Indications: 

Lendomy 5 mg is clinically indicated for several complex oncology conditions:

• Multiple Myeloma (MM): Used in combination with dexamethasone for patients who have received at least one prior therapy or for newly diagnosed patients.

• Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

• Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after prior therapies.

• Follicular Lymphoma & Marginal Zone Lymphoma: In combination with rituximab for previously treated patients.

Mechanism of Action: How Lendomy 5 mg Works :

Lendomy (Lenalidomide) operates through a multi-faceted biological pathway:

1. Immune System Activation: It enhances the activity of T cells and Natural Killer (NK) cells, empowering the body's natural defenses to identify and destroy cancer cells.

2. Anti-Angiogenesis: It inhibits the growth of new blood vessels within tumors, essentially starving the tumor of the nutrients required to expand.

3. Direct Tumor Inhibition: It induces cell cycle arrest and apoptosis (programmed cell death) in hematopoietic tumor cells.

4. Cytokine Regulation: It alters the production of inflammatory cytokines (like TNF-alpha), creating an environment that is hostile to tumor survival.

Dosage and Administration Guidelines: 

• Cycle Schedules: Usually prescribed in 28-day cycles (e.g., one capsule daily for 21 days, followed by a 7-day rest period).

• Administration: Capsules should be swallowed whole with water at the same time each day. They can be taken with or without food.

• Handling: Due to the potency of the medication, capsules should not be opened or crushed.

• Safety Protocols: Because of the risk of embryo-fetal toxicity, Lendomy is typically distributed under strict pregnancy prevention programs (REMS) globally.

Side Effects & Patient Monitoring

Healthcare providers should closely monitor patients for the following:

• Neutropenia & Thrombocytopenia: Regular blood counts (CBC) are essential, as the drug can lower white blood cell and platelet levels.

• Venous Thromboembolism: An increased risk of blood clots; preventative anticoagulants are often recommended.

• Fatigue & Gastrointestinal Issues: Common side effects include tiredness, diarrhea, or nausea.

Why Partner with Ernest Oncology for Lendomy 5 mg?

• Global Logistics Mastery: Expertise in direct shipping and customs handling for the USA, UK, UAE, Australia, and South Africa.

• Quality Assurance: Authentic oncology medications sourced from GMP-compliant manufacturers in India.

• Bulk Supply Capability: Consistent inventory management of 5mg, 10mg, 15mg, and 25mg strengths for hospital and clinical supply.

• Competitive B2B Pricing: Optimized rates for international pharmaceutical distributors and oncology centers.